This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
The Potential of SARMs and Antimyostatin Agents in Addressing Lean Body Mass Loss From GLP-1 Agonists: A Literature Review.
Journal of diabetes, 17(8), e70119
Citation
Wen, Jimmy; Ansari, Ubaid; Shehabat, Mouhamad; Ansari, Zaid; Syed, Burhaan; Razick, Adam; Razick, Daniel; Akhtar, Muzammil; Frezza, Eldo. (2025). The Potential of SARMs and Antimyostatin Agents in Addressing Lean Body Mass Loss From GLP-1 Agonists: A Literature Review.. Journal of diabetes, 17(8), e70119. https://doi.org/10.1111/1753-0407.70119